123 related articles for article (PubMed ID: 9373199)
1. The functional phenotype of the primitive plasma cell in patients with multiple myeloma correlates with the clinical state.
Pope B; Brown RD; Gibson J; Petersen A; Wiley J; Joshua DE
Leuk Lymphoma; 1997 Sep; 27(1-2):83-91. PubMed ID: 9373199
[TBL] [Abstract][Full Text] [Related]
2. The labelling index of primitive plasma cells determines the clinical behaviour of patients with myelomatosis.
Joshua D; Petersen A; Brown R; Pope B; Snowdon L; Gibson J
Br J Haematol; 1996 Jul; 94(1):76-81. PubMed ID: 8757512
[TBL] [Abstract][Full Text] [Related]
3. Multiple myeloma: expression of nucleoside transporters on malignant plasma cells and their relationship to cellular proliferation.
Petersen AJ; Brown RD; Pope BB; Jamieson GP; Paterson AR; Gibson J; Wiley JS; Joshua DE
Leuk Lymphoma; 1994 May; 13(5-6):491-9. PubMed ID: 8069194
[TBL] [Abstract][Full Text] [Related]
4. The clonal hierachy in multiple myeloma.
Rasmussen T; Jensen L; Johnsen HE
Acta Oncol; 2000; 39(7):765-70. PubMed ID: 11145430
[TBL] [Abstract][Full Text] [Related]
5. Tumor-specific aneuploidy not detected in CD19+ B-lymphoid cells from myeloma patients in a multidimensional flow cytometric analysis.
McSweeney PA; Wells DA; Shults KE; Nash RA; Bensinger WI; Buckner CD; Loken MR
Blood; 1996 Jul; 88(2):622-32. PubMed ID: 8695810
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
7. A novel multiparametric approach for analysis of cytoplasmic immunoglobulin light chains by flow cytometry.
Chang CC; Schur BC; Kampalath B; Lindholm P; Becker CG; Vesole DH
Mod Pathol; 2001 Oct; 14(10):1015-21. PubMed ID: 11598172
[TBL] [Abstract][Full Text] [Related]
8. Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen.
Schneider U; van Lessen A; Huhn D; Serke S
Br J Haematol; 1997 Apr; 97(1):56-64. PubMed ID: 9136942
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of CD38/45 flow cytometry and immunofluorescence microscopy to detect blood plasma cells in patients with plasma cell proliferative disorders.
Witzig TE; Meyers C; Therneau T; Greipp PR
Leuk Lymphoma; 2000 Jul; 38(3-4):345-50. PubMed ID: 10830741
[TBL] [Abstract][Full Text] [Related]
10. Plasma cells in peripheral blood stem cell harvests from patients with multiple myeloma are predominantly polyclonal.
Pope B; Brown R; Gibson J; Joshua D
Bone Marrow Transplant; 1997 Aug; 20(3):205-10. PubMed ID: 9257888
[TBL] [Abstract][Full Text] [Related]
11. Plasma cells composing plasmacytoma have phenotypes different from those of myeloma cells.
Sakai A; Fujii T; Noda M; Hyodo H; Oda K; Kimura A
Am J Hematol; 1996 Dec; 53(4):251-3. PubMed ID: 8948665
[TBL] [Abstract][Full Text] [Related]
12. Phenotyping primitive plasma cells.
Joshua D; Pope B; Brown R; Brown L; Murray A; Gibson J
Br J Haematol; 2002 Apr; 117(1):252-3. PubMed ID: 11918567
[No Abstract] [Full Text] [Related]
13. In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain.
Bergsagel PL; Smith AM; Szczepek A; Mant MJ; Belch AR; Pilarski LM
Blood; 1995 Jan; 85(2):436-47. PubMed ID: 7529064
[TBL] [Abstract][Full Text] [Related]
14. Detection of myeloma cells in the peripheral blood by flow cytometry.
Witzig TE; Kimlinger TK; Ahmann GJ; Katzmann JA; Greipp PR
Cytometry; 1996 Jun; 26(2):113-20. PubMed ID: 8817086
[TBL] [Abstract][Full Text] [Related]
15. [Detection of myeloma cells in peripheral blood using multi-parameter flow cytometry: monitoring residual disease].
Klabusay M; Doubek M; Adam Z; Hájek R; Krivanová A
Cas Lek Cesk; 2000 Jul; 139(14):432-6. PubMed ID: 11048405
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic analysis of plasma cells in bone marrow using flow cytometry in AL amyloidosis.
Matsuda M; Gono T; Shimojima Y; Hoshii Y; Ikeda S
Amyloid; 2003 Jun; 10(2):110-6. PubMed ID: 12964418
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.
Santonocito AM; Consoli U; Bagnato S; Milone G; Palumbo GA; Di Raimondo F; Stagno F; Guglielmo P; Giustolisi R
Leuk Res; 2004 May; 28(5):469-77. PubMed ID: 15068900
[TBL] [Abstract][Full Text] [Related]
18. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
Kimlinger T; Witzig TE
Bone Marrow Transplant; 1997 Mar; 19(6):553-6. PubMed ID: 9085734
[TBL] [Abstract][Full Text] [Related]
19. Decreased numbers of circulating B cells in myeloma patients with reduction after conventional chemotherapy.
Kallmeyer C; Wallmeier M; Kiel K; Moos M; Hegenbart U; Haas R; Goldschmidt H
Am J Hematol; 1998 Apr; 57(4):287-92. PubMed ID: 9544972
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry.
Terstappen LW; Johnsen S; Segers-Nolten IM; Loken MR
Blood; 1990 Nov; 76(9):1739-47. PubMed ID: 2224123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]